Javascript must be enabled to continue!
Retrospective Analysis of ECMO for Acute Fulminant Viral Myocarditis
View through CrossRef
Background The inflammation or degeneration of the heart muscle myocarditis may be fatal. This disease often goes undetected. It may also disguise itself as ischemic valvular or hypertensive heart disease. Here we report eight cases of acute fulminant viral myocarditis suffering from low cardiac output ARDS Acute respiratory distress syndrome formation and successfully treated with ECMO Extra corporeal membrane oxygenation.Methodology All the cases were admitted in the emergency coronary care unit with severe respiratory distress poor hemodynamics and ECHO examination revealed low Left ventricle Ejection Fraction LVEF15-20. Veno - Arterial ECMO was initiated with femoro-femoral cannulation with distal limb perfusion. On ECMO support the hemodynamics were stabilized with no inotropic support. The heart and lungs were given adequate rest time for recovery by maintaining total cardiac output on ECMO. The average ECMO support was 84.2 plusmn 4 hours. Maquet Quadrox PLS Sorin Dideco ECMO oxygenators with rotaflow centrifugal pump were used. Delta pressure pre-pump pressures were continuously monitored.Results Out of the eight cases put on VA ECMO for viral myocarditis seven were successfully weaned off and were discharged success rate of 87.5. Soon after the initiation of ECMO the arterial saturation reached the normal levels. The serum lactate levels which were high gt6 mmolL prior to initiation of ECMO remarkably came down to lt2 mmolL after 24 hours. Seven patients were weaned off and decannulated in the operating room. One patient required LV decompression by Balloon Atrial Septostomy in the Hybrid OR and was successfully weaned off after 48 hours. One patient succumbed due to continuous low cardiac output which was irreversible with full blown septicemia and was not responding to ECMO and medications.Conclusion Peripheral VA-ECMO support is very effective in optimizing myocardial recovery for the treatment of refractory acute fulminant viral myocarditis when maximal conventional supports are ineffective.
Rajiv Gandhi University of Health Sciences
Title: Retrospective Analysis of ECMO for Acute Fulminant Viral Myocarditis
Description:
Background The inflammation or degeneration of the heart muscle myocarditis may be fatal.
This disease often goes undetected.
It may also disguise itself as ischemic valvular or hypertensive heart disease.
Here we report eight cases of acute fulminant viral myocarditis suffering from low cardiac output ARDS Acute respiratory distress syndrome formation and successfully treated with ECMO Extra corporeal membrane oxygenation.
Methodology All the cases were admitted in the emergency coronary care unit with severe respiratory distress poor hemodynamics and ECHO examination revealed low Left ventricle Ejection Fraction LVEF15-20.
Veno - Arterial ECMO was initiated with femoro-femoral cannulation with distal limb perfusion.
On ECMO support the hemodynamics were stabilized with no inotropic support.
The heart and lungs were given adequate rest time for recovery by maintaining total cardiac output on ECMO.
The average ECMO support was 84.
2 plusmn 4 hours.
Maquet Quadrox PLS Sorin Dideco ECMO oxygenators with rotaflow centrifugal pump were used.
Delta pressure pre-pump pressures were continuously monitored.
Results Out of the eight cases put on VA ECMO for viral myocarditis seven were successfully weaned off and were discharged success rate of 87.
5.
Soon after the initiation of ECMO the arterial saturation reached the normal levels.
The serum lactate levels which were high gt6 mmolL prior to initiation of ECMO remarkably came down to lt2 mmolL after 24 hours.
Seven patients were weaned off and decannulated in the operating room.
One patient required LV decompression by Balloon Atrial Septostomy in the Hybrid OR and was successfully weaned off after 48 hours.
One patient succumbed due to continuous low cardiac output which was irreversible with full blown septicemia and was not responding to ECMO and medications.
Conclusion Peripheral VA-ECMO support is very effective in optimizing myocardial recovery for the treatment of refractory acute fulminant viral myocarditis when maximal conventional supports are ineffective.
Related Results
Appropriate timing of veno-arterial extracorporeal membrane oxygenation initiation after cardiac surgery
Appropriate timing of veno-arterial extracorporeal membrane oxygenation initiation after cardiac surgery
Abstract
Background
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can be initiated during cardiac surgery or later in ICU according to...
ECMO physiology
ECMO physiology
Temporary mechanical cardiopulmonary support may be used intraoperatively to facilitate cardiac surgery. Over the past decade, this intervention has been extended for prolonged use...
Hemodynamic analysis of left ventricular unloading with Impella versus IABP during VA-ECMO
Hemodynamic analysis of left ventricular unloading with Impella versus IABP during VA-ECMO
Purpose
The utilization of intra-aortic balloon pump (IABP) and Impella has been suggested as means of left ventricular unloading in veno-arterial extracorporeal membrane oxyg...
Treatment strategy for acute myocarditis in pediatric patients requiring emergency intervention
Treatment strategy for acute myocarditis in pediatric patients requiring emergency intervention
Abstract
Background
Patients with acute myocarditis present with a wide range of symptoms. Treatment strategies for pedia...
Treatment Strategy for Acute Myocarditis in Pediatric Patients Requiring Emergency Intervention
Treatment Strategy for Acute Myocarditis in Pediatric Patients Requiring Emergency Intervention
Abstract
Background: Patients with acute myocarditis present with a wide range of symptoms. Treatment strategies for pediatric patients with circulatory failure comprise ex...
Integrated Bioinformatics analysis and Metabolomic Responses in finding novel therapeutic approach to treat viral myocarditis
Integrated Bioinformatics analysis and Metabolomic Responses in finding novel therapeutic approach to treat viral myocarditis
Abstract
Background
Myocarditis is one of the most common health problems in young people. Despite imaging...
Application of in Vitro Membrane Pulmonary Oxygenation Technology (ECMO) in Neonatal Respiratory Failure
Application of in Vitro Membrane Pulmonary Oxygenation Technology (ECMO) in Neonatal Respiratory Failure
Objective: To explore the application of Extracorporeal Membrane Oxygenation technology (ECMO) in neonatal respiratory failure and provide guidance for future ECMO technology for c...
Brief Overview of the Use of Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients with Severe Acute Respiratory Distress Syndrome (ARDS)
Brief Overview of the Use of Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients with Severe Acute Respiratory Distress Syndrome (ARDS)
Background
A serious complication of coronavirus disease 2019 (COVID-19) is acute respiratory distress syndrome (ARDS). Hypoxemia refractory to traditional management, including in...

